RANI — RANI THERAPEUTICS HLDGS INC

Ownership history in ACT Advisors, LLC.  ·  2 quarters on record

This page tracks every 13F SEC filing in which ACT Advisors, LLC. reported a position in RANI THERAPEUTICS HLDGS INC (RANI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q4)
Avg. % of fund
0.01%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 16,062 +1,256 +8.5% 0.01% $22K $1.35
2025 Q3 INITIATED 14,806 — — 0.00% $7K $0.50
% of Fund (quarterly)    RANI price (monthly, adj. close)

Other funds also holding RANI

As of 2025 Q4 — sorted by position size

Samsara BioCapital, LLC 3Y 7Y 1.18% AWM Investment Company, Inc. 3Y 7Y 0.85% Nan Fung Group Holdings Ltd 3Y 0.6% Longaeva Partners L.P. 0.24% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.12% Siren, L.L.C. 0.08% 683 Capital Management, LLC 3Y 7Y 0.03% UNITED SERVICES AUTOMOBILE ASSOCIATION 3Y 7Y 0.03% Well Done, LLC 3Y 7Y 0.01% ISLAY CAPITAL MANAGEMENT, LLC 3Y 0.01%
← Back to ACT Advisors, LLC. Holdings